First RCT in COVID Anticoagulation Says Go Full Dose

(MedPage Today) -- Therapeutic-level dosing of enoxaparin (Lovenox) improved respiratory outcomes in severe COVID-19, a pilot randomized trial showed.
Gas exchange measured by the PaO2/FiO2 ratio improved significantly over time in the 10-patient...